---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-22-000047"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2022-11-01T23:59:59+00:00"
generated_at: "2026-06-22T18:28:56.768805+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Q3 revenue $109.2M (+77% YoY); raises FY2022 guidance to $384-388M

## Summary
- Revenue $109.2M (+77% YoY); raised FY2022 guidance to $384-388M from $354-362M.
- Gross margin 81.9% (down from 86.0%) on inventory obsolescence and inflation; FY margin guidance maintained at 83-85%.
- Net loss $16.8M ($0.60 diluted EPS) vs $10.3M ($0.38); cash $427.5M after $243.8M public offering.
- Added 59 new U.S. centers (total 844) and 18 sales territories (total 209); launched Bluetooth remote and silicone leads.
- European revenue down 14% on FX; France final pricing secured, reimbursement expected early 2023.

## SEC filing metadata
- accession: 0001609550-22-000047
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2022-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955022000047/0001609550-22-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955022000047/insp-20221101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-22-000047
- JSON: https://secwatch.observer/filing/0001609550-22-000047.json
- Plain text: https://secwatch.observer/filing/0001609550-22-000047.txt

## Key facts
- Earnings Releases
  Inspire Medical Systems, Inc. reported quarter ended September 30, 2022 results: revenue $109.2 million. Guidance raised.
  - Period: quarter ended September 30, 2022
  - Revenue: $109.2 million
  - Guidance: raised
  - Result: reported results
  source text: solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2022. Recent Business Highlights • Generated revenue of $109.2 million in the third quarter of 2022, a 77% increase over the same quarter last year • Achieved gross margin of 81.9% in the third quarter of 2022 • Activated 59 new centers in the U.S.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955022000047/0001609550-22-000047-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.